Trials / Completed
CompletedNCT01682382
Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)
Collection of Whole Blood Specimens and Buccal Swabs From Subjects Diagnosed With CNV AMD, Dry AMD, and Age-Matched Controls to Assess the Association of Genetic Variants in Complement Factor H With Risk of Progression to CNV.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (actual)
- Sponsor
- Sequenom, Inc. · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Accepted
Summary
Subjects with wet AMD, dry AMD, and age-matched controls will undergo routine occular measurements, will provide a blood and cheek cell sample, and will have macular pigment optical density (MPOD) measured to determine if there is an association between genetics, MPOD and the risk of progression to wet AMD.
Conditions
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2013-08-01
- Completion
- 2013-10-01
- First posted
- 2012-09-10
- Last updated
- 2014-01-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01682382. Inclusion in this directory is not an endorsement.